Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yao-Feng Chong"'
Autor:
Sean Tan, Clare Elisabeth Si Min Ho, Yao Neng Teo, Yao Hao Teo, Mark Yan-Yee Chan, Chi-Hang Lee, Lauren Kay Mance Evangelista, Weiqin Lin, Yao-Feng Chong, Tiong-Cheng Yeo, Vijay Kumar Sharma, Raymond C. C. Wong, Benjamin Y. Q. Tan, Leonard L. L. Yeo, Ping Chai, Ching-Hui Sia
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionHeart failure (HF) is associated with ischemic stroke (IS). However, there are limited studies on the prevalence of IS, white matter hyperintensities (WMHs), and silent brain infarcts (SBIs). Furthermore, interaction with ejection fractio
Externí odkaz:
https://doaj.org/article/69eda916e7da451889834c46a7fd77b7
Autor:
Nicole Li Xian Yap, Qianyi Kor, Yao Neng Teo, Yao Hao Teo, Nicholas L. Syn, Lauren Kay Mance Evangelista, Benjamin YQ. Tan, Weiqin Lin, Leonard LL. Yeo, William KF. Kong, Yao Feng Chong, Raymond CC. Wong, Kian Keong Poh, Tiong-Cheng Yeo, Vijay Kumar Sharma, Ping Chai, Mark Y. Chan, Fang Qin Goh, Ching-Hui Sia
Publikováno v:
Hellenic Journal of Cardiology, Vol 67, Iss , Pp 48-58 (2022)
Introduction: The burden of cognitive impairment in heart failure (HF) patients is significant and leads to longer hospital stay, higher readmission rates, and increased mortality. This review seeks to synthesize the available studies to determine th
Externí odkaz:
https://doaj.org/article/1124eebef0204526939ab820ede0165e
Autor:
Yilong Zheng, Mervyn Jun Rui Lim, Benjamin Yong-Qiang Tan, Bernard Poon Lap Chan, Prakash Paliwal, Ong Jia Yuan Jonathan, Chandra Bharatendu, Amanda Chee Yun Chan, Leonard Leong Litt Yeo, Joy Vijayan, Chiew S. Hong, Young Heng Chee, Lily Y. H. Wong, Jintao Chen, Victor Yao Feng Chong, Yanhong Dong, Chi Hsien Tan, Sibi Sunny, Hock Luen Teoh, Arvind Kumar Sinha, Vijay Kumar Sharma
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
ObjectivePrior studies have shown that plaque inflammation on FDG-PET and the symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL) score were associated with recurrent ischemic events, but the findings have thus far not been widely valida
Externí odkaz:
https://doaj.org/article/3a27d632b0044559825c8cfebd4001f0
Autor:
Elizabeth Hui En Thong, Ethan J. W. Quek, Jing Hong Loo, Choi-Ying Yun, Yao Neng Teo, Yao Hao Teo, Aloysius S. T. Leow, Tony Y. W. Li, Vijay K. Sharma, Benjamin Y. Q. Tan, Leonard L. L. Yeo, Yao Feng Chong, Mark Y. Chan, Ching-Hui Sia
Publikováno v:
Biology, Vol 12, Iss 8, p 1154 (2023)
Cognitive impairment (CI) shares common cardiovascular risk factors with acute myocardial infarction (AMI), and is increasingly prevalent in our ageing population. Whilst AMI is associated with increased rates of CI, CI remains underreported and infr
Externí odkaz:
https://doaj.org/article/797eab97a64d487d9e61a2595bbab247
Autor:
Fang Qin Goh, William K. F. Kong, Raymond C. C. Wong, Yao Feng Chong, Nicholas W. S. Chew, Tiong-Cheng Yeo, Vijay Kumar Sharma, Kian Keong Poh, Ching-Hui Sia
Publikováno v:
Biology, Vol 11, Iss 2, p 179 (2022)
Cognitive impairment (CI) is common in heart failure (HF). Patients with HF demonstrate reduced global cognition as well as deficits in multiple cognitive domains compared to controls. Degree of CI may be related to HF severity. HF has also been asso
Externí odkaz:
https://doaj.org/article/8db6c928519a41da8ae013008d13f34f
Autor:
Jackie Jia Lin Sim, Ryan Ruiyang Ling, Vernicia Shu Qi Neo, Felicia Liying Tan, Andie Hartanto Djohan, Leonard L.L. Yeo, Keith Andrew Chan, Yinghao Lim, Benjamin Y.Q. Tan, Tiong-Cheng Yeo, Mark Y. Chan, Kian-Keong Poh, William K.F. Kong, James W.L. Yip, Yao Feng Chong, Vijay K. Sharma, Ivandito Kuntjoro, Ching-Hui Sia
Publikováno v:
The American Journal of Cardiology. 185:63-70
This study sought to investigate the impact of pre-existing cognitive impairment on outcomes after transcatheter aortic valve implantation (TAVI). TAVI has been increasingly used in seniors, and evidence suggests better outcomes than surgical aortic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d075c348ace8039346c9938d65a1eedc
https://doi.org/10.1016/j.amjcard.2022.09.010
https://doi.org/10.1016/j.amjcard.2022.09.010
Autor:
Ti Myen Tan, Herbert Schwarz, Nur Hafiza Ismail, Jonathan J. Y. Ong, Poh San Lai, Vivek Sharma, Anselm Mak, Hiu Yi Wong, Bharatendu Chandra, Chi Hsien Tan, Alison Ying Ying Ng, Einar Wilder-Smith, Amanda C.Y. Chan, Yao Feng Chong, Hyungwon Choi, Kay W.P. Ng, Yee Cheun Chan, Nurul H Rutt, Jennifer H M Hung, Joy Vijayan, Hock Luen Teoh
Publikováno v:
Chan, Amanda C Y; Wong, Hiu Yi; Chong, Yao Feng; Lai, Poh San; Teoh, Hock Luen; Ng, Alison Y Y; Hung, Jennifer H M; Chan, Yee Cheun; Ng, Kay W P; Vijayan, Joy; Ong, Jonathan J Y; Chandra, Bharatendu; Tan, Chi Hsien; Rutt, Nurul H; Tan, Ti Myen; Ismail, Nur Hafiza; Wilder-Smith, Einar; Schwarz, Herbert; Choi, Hyungwon; Sharma, Vijay K; ... (2022). Novel Autoantibodies in Idiopathic Small Fiber Neuropathy. Annals of neurology, 91(1), pp. 66-77. Wiley-Blackwell 10.1002/ana.26268
OBJECTIVE Small fiber neuropathy (SFN) is clinically and etiologically heterogeneous. Although autoimmunity has been postulated to be pathophysiologically important in SFN, few autoantibodies have been described. We aimed to identify autoantibodies a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473b62ab29687643ca26389def6cce10
https://doi.org/10.1002/ana.26268
https://doi.org/10.1002/ana.26268
Publikováno v:
Alzheimer's & Dementia. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5253d4d6aeb15b357662597b62393b3c
https://doi.org/10.1002/alz.068916
https://doi.org/10.1002/alz.068916
Autor:
Yilong Zheng, Mervyn Jun Rui Jun Rui Lim, Benjamin Tan, Bernard Chan, Prakash Paliwal, Jonathan Ong, Chandra Bharatendu, Amanda Chan, Leonard Yeo, Joy Vijayan, Young Heng Chee, Lily Wong, Jintao Chen, Yao Feng Chong, Yanhong Dong, Chi Hsien Tan, Sibi Sunny, Hock Luen Teoh, Arvind Kumar Sinha, Vijay Sharma
Publikováno v:
Neurosurgery. 69:74-74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf728288e6c876f7fd809c496b9aa629
https://doi.org/10.1227/neu.0000000000002375_399
https://doi.org/10.1227/neu.0000000000002375_399
Autor:
Thahesh Tharmaraja, Jamie S.Y. Ho, Ching-Hui Sia, Nicole-Ann Lim, Yao Feng Chong, Amanda Y.L. Lim, Rahul R. Rathakrishnan, Leonard L.L. Yeo, Vijay K. Sharma, Benjamin Y.Q. Tan
Publikováno v:
Therapeutic advances in chronic disease. 13
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a group of antidiabetic medications with a favourable cardiovascular, renal and overall safety profile. Given the limited treatment options available for neurological disorders, it is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b49a20d93c247aad69c83c0e38c4d2
https://pubmed.ncbi.nlm.nih.gov/35432846
https://pubmed.ncbi.nlm.nih.gov/35432846